Research Article
Efficacy and Safety of Levetiracetam and Carbamazepine as Monotherapy in Partial Seizures
Table 1
Overall characteristics of patients on Levetiracetam and Carbamazepine monotherapy.
| | | CBZ group | LEV group | value | | = 28 | = 28 |
| | Male mean age | 30.70 ± 2.66 yrs | 22.62 ± 1.152 yrs | 0.0834 | | Female mean age | 29.31 ± 2.44 yrs | 28.18 ± 2.553 yrs | 0.7101 | | Mean BMI | 22.56 ± 0.41 | 21.49 ± 0.41 | 0.0690 | | Pretreatment mean seizure frequency | 2.83 ± 0.19 | 4.2 ± 0.65 | 0.0470 | | Seizure freedom at 4 weeks | 85.72% | 85.72% | 1.0000 | | Seizure freedom at 12 weeks | 89.29% | 93.34% | 0.4595 | | Seizure freedom at 26 weeks | 96.43% | 100% | 0.1212 | | Overall seizure freedom at 6 months | 71.42% | 78.57% | 0.2529 | | QOL at 0 weeks | 31.14 ± 1.83 | 29.76 ± 1.71 | 0.5861 | | QOL at 26th week | 58.41 ± 1.89 | 64.58 ± 2.02 | 0.0302 |
|
|
